Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller?Cemil Bilir, M.D. a , Can Sarisozen, PhD ba Sakarya University School of Medicine, Department of Medical Oncology, Turkey
b Northeastern University, Center for Pharmaceutical Biotechnology and Nanomedicine, USADOI: https://doi.org/10.1016/j.jons.2017.04.001 Sayfalar: 52 - 56 1931 Viewed.
JOURNAL of
EN